Na Zhou

机构：Xihua University, Macau University of Science and Technology, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, University of Chicago, Shenyang 242 Hospital · ORCID：0000-0002-3808-1323

发表论文 47 篇 · 总被引 740 次 · h-index 16

代表论文

• Intracellularly Synthesized Artificial Exosome Treats Acute Lung Injury (2024 · ACS Nano · 被引 33)
• Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients (2023 · Frontiers in Immunology · 被引 24)
• Anti-PD-1 antibodies, a novel treatment option for advanced chemoresistant pulmonary lymphoepithelioma carcinoma (2022 · Frontiers in Immunology · 被引 19)
• Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression (2021 · BMC Pulmonary Medicine · 被引 18)
• Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study (2024 · Frontiers in Immunology · 被引 13)
• CD206 modulates the role of M2 macrophages in the origin of metastatic tumors (2024 · Journal of Cancer · 被引 13)